$KLAC

WALLACE RICHARD P sold $17.4M of KLAC

WALLACE RICHARD P (President and CEO) sold 87,568 shares of KLA CORP (KLAC) at $198.95 ($17.42M total) on 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WALLACE RICHARD P
Published Aug 12, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KLAC
Neutral
medium confidence
Mentioned
$KLAC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLACNeutralLow
01

Why it matters

Traders may briefly reassess sentiment around management confidence, but the pre-arranged nature typically makes it less actionable than unscheduled selling or other fundamental disclosures.

02

Market read

A CEO sold about $17.42M of KLAC stock at a stated price, disclosed via Form 4 with a 10b5-1 plan.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-scheduled plans; without changes in guidance or operating news, the trading edge is limited.

Relevance 6/10Novelty 4/10Timing: filed after-hours on 2026-08-12, covering a sale dated 2026-08-11

Background

The article is a SEC Form 4 insider transaction disclosure for KLA Corp, listing the CEO’s role and a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$KLACNeutralMedium confidence
Context

KLA insider Wallace Richard P sold 87,568 shares at $198.95 each for about $17.42M under a pre-arranged 10b5-1 plan.

Expected impact

Near-term impact likely limited; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is a primary Form 4 disclosure with transaction size and price, but it is explicitly tied to a pre-arranged 10b5-1 plan, which typically limits interpretive value for near-term fundamentals.

Market effects

No direct sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity planning under a 10b5-1 plan, so it should not be treated as a bearish fundamental signal.

Key entities

  • KLA Corp

    Subject of the Form 4 insider sale disclosure.

  • Wallace Richard P

    President and CEO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$KLACMedAI 8/10

KLA Gains From Advanced Packaging: Can it Outpace ONTO & AMAT?

KLA (KLAC) is seeing growth in advanced packaging due to AI and HPC chip demand, expecting $1.1B in 2026 revenue. Competitors Onto Innovation (ONTO) and Applied Materials (AMAT) are also expanding in this sector. KLAC's stock is up 50.9% YTD, with a forward P/S of 13.05X. Analysts estimate 2027 earnings at $5.43 per share, up 7.1% in 30 days.

$KLACHighAI 8/10

Is Wall Street Bullish or Bearish on KLA Corporation Stock?

KLA Corporation (KLAC) reported strong Q4 2026 results with revenue up 15.1% to $3.66B and adjusted EPS of $1.05, beating estimates. The company's Q1 2027 guidance also exceeded consensus. Shares have surged 110.9% over 52 weeks, outperforming the S&P 500. Analysts expect 44.2% EPS growth for FY 2027, with a consensus 'Moderate Buy' rating and a mean price target of $237.81.

$KLACHighAI 9/10

KLA Corporation: See What Wall Street Sees

KLA Corporation (KLAC) dropped 14% in a month despite strong market position and raised revenue guidance. The company reported Q4 revenue of $3.66B, up 15% YoY, and raised its 2026 outlook. CEO Rick Wallace sold 87,568 shares. The stock trades at a 34 forward P/E, with concerns around China export controls and insider sales.

$KLACMed

Can KLA's Advanced Packaging Strength Support $1B Revenue Target?

KLA (KLAC) says advanced packaging revenues in its semiconductor process control portfolio should rise to nearly $1B in 2026 from about $635M in 2025, citing stronger customer demand. The company reported advanced wafer-level packaging revenue up nearly 70% YoY in 2025 and expects growth weighted to H2 2026, supported by AI-driven semiconductor complexity and CoWoS/SoIC demand.

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.